Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales

• Hauptverfasser: Amy Y. Kang (Verfasst von), Mary Elkomos (Verfasst von), Danny Pham (Verfasst von), Michelle Guerrero (Verfasst von), Deborah Kupferwasser (Verfasst von), Loren G. Miller (Verfasst von)
• Format: Buch
• Veröffentlicht: Cambridge University Press, 2024-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

ABSTRACT Objective: To investigate whether empiric carbapenem therapy, compared to empiric non-carbapenem therapy, was associated with improved clinical outcomes among hospitalized, non-intensive care unit (ICU) patients with extended-spectrum β-lactamase (ESBL)-producing Enterobacterales infections...